Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?

Introduction Faster insulin aspart (fASP) is the new formulation of insulin aspart (ASP) with a left-shifted pharmacokinetic profile, allowing better control of early postprandial hyperglycemia and a reduction in the risk of late post-meal hypoglycemia. However, it can be associated with more freque...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosinha, Patrícia, Teixeira, Sofia, Vilaverde, Joana, Cardoso, Maria Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509526/
https://www.ncbi.nlm.nih.gov/pubmed/36176818
http://dx.doi.org/10.7759/cureus.28422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509526/
https://www.ncbi.nlm.nih.gov/pubmed/36176818
http://dx.doi.org/10.7759/cureus.28422

Ejemplares similares